GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AgeX Therapeutics Inc (STU:0X40) » Definitions » FCF Yield %

AgeX Therapeutics (STU:0X40) FCF Yield % : -28.10 (As of Jun. 23, 2024)


View and export this data going back to 2020. Start your Free Trial

What is AgeX Therapeutics FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, AgeX Therapeutics's Trailing 12-Month Free Cash Flow is €-7.24 Mil, and Market Cap is €25.61 Mil. Therefore, AgeX Therapeutics's FCF Yield % for today is -28.10%.

The historical rank and industry rank for AgeX Therapeutics's FCF Yield % or its related term are showing as below:

STU:0X40' s FCF Yield % Range Over the Past 10 Years
Min: -65.13   Med: -22.56   Max: -4.06
Current: -28.1


During the past 7 years, the highest FCF Yield % of AgeX Therapeutics was -4.06%. The lowest was -65.13%. And the median was -22.56%.

STU:0X40's FCF Yield % is not ranked
in the Biotechnology industry.
Industry Median: -14.395 vs STU:0X40: -28.10

AgeX Therapeutics's FCF Margin % for the quarter that ended in Dec. 2023 was -2,650.70%.


AgeX Therapeutics FCF Yield % Historical Data

The historical data trend for AgeX Therapeutics's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AgeX Therapeutics FCF Yield % Chart

AgeX Therapeutics Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
FCF Yield %
Get a 7-Day Free Trial - -13.56 -37.09 -28.97 -54.47

AgeX Therapeutics Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -25.77 -30.60 -27.67 -28.55 -57.33

Competitive Comparison of AgeX Therapeutics's FCF Yield %

For the Biotechnology subindustry, AgeX Therapeutics's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AgeX Therapeutics's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, AgeX Therapeutics's FCF Yield % distribution charts can be found below:

* The bar in red indicates where AgeX Therapeutics's FCF Yield % falls into.



AgeX Therapeutics FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

AgeX Therapeutics's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-7.153 / 13.131108704
=-54.47%

AgeX Therapeutics's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-1.882 * 4 / 13.131108704
=-57.33%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


AgeX Therapeutics FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


AgeX Therapeutics FCF Yield % Related Terms

Thank you for viewing the detailed overview of AgeX Therapeutics's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


AgeX Therapeutics (STU:0X40) Business Description

Traded in Other Exchanges
N/A
Address
1101 Marina Village Parkway, Suite 201, Alameda, CA, USA, 94501
AgeX Therapeutics Inc is a biotechnology company engaged in the development and commercialization of novel therapeutics targeting human aging. The firm through its PureStem and induced Tissue Regeneration (iTR) technologies develops medicines designed to address some of the unsolved problems in aging. Its PureStem-derived cell-based therapeutic candidates in development are AGEX-VASC1, AGEX-BAT1 and AGEX-iTR1547.

AgeX Therapeutics (STU:0X40) Headlines

No Headlines